Clinical Trials Browser

Phase 2 × ibritumomab tiuxetan × 1 year × Clear all

NCT00690560 2025-09-30

Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma

Phase 2 Completed

Lymphoma, Lymphoma, Large B-Cell, Diffuse